ESYA
Esya is a biotech company that measures, monitors, assist drug development, and pre-assess patient cohorts for treatment.
ESYA
Industry:
Biotechnology Life Science
Founded:
2018-10-01
Address:
Newbury, West Berkshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.esyalabs.com
Total Employee:
1+
Status:
Active
Total Funding:
400 K USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Wix DNS
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
George Shultz Innovation Fund
George Shultz Innovation Fund investment in Grant - Esya
Official Site Inspections
http://www.esyalabs.com
- Host name: mta-32.merchantbio.nl
- IP address: 191.96.54.32
- Location: Lincoln United States
- Latitude: 40.8161
- Longitude: -96.7036
- Metro Code: 722
- Timezone: America/Chicago
- Postal: 68508
More informations about "Esya"
About Us - Esya Labs
Markus is a seasoned finance professional and technology-driven company builder. He brings 15 years of experience across Private Equity and business consulting and has focused on helping โฆSee details»
Esya - Crunchbase Company Profile & Funding
Esya is a biotech company that measures, monitors, assist drug development, and pre-assess patient cohorts for treatment.See details»
Esya Labs Company Profile 2024: Valuation, Funding
Esya Labs General Information Description. Developer of a nanotechnology device designed to diagnose dementia and other neurodegenerative diseases. The company's device conducts a simple blood test or skin biopsy to measure โฆSee details»
EsyaLabs - GitHub
We combine patented intracellular analytics using DNA nanoprobes with AI to diagnose Alzheimer's Disease before symptoms manifest. - EsyaLabsSee details»
Dhivya Venkat - Co-Founder & Chief Executive Officer
Primary Organization . Esya . Location London, England, United Kingdom; Regions Europe, Middle East, and Africa (EMEA) Gender Female; Website www.esyalabs.com ; LinkedIn View on LinkedIn ; Twitter View on Twitter ; โฆSee details»
Contact Us - Esya Labs
[email protected] We are a start-up originally spun out of Dr. Yamuna Krishnanโs lab at the University of Chicago, now based across London, UK, and the U.S. CONTACT. [email protected] Esya Labs, Translation & Innovation โฆSee details»
Esya Labs - LinkedIn
Dhivya Venkat from Esya Labs highlights the importance of integrating innovative diagnostics and FDA-approved therapies, like anti-amyloid treatments, into the NHS. With dementia rates on โฆSee details»
Esya Labs - Overview, News & Competitors | ZoomInfo.com
View Esya Labs (www.esyalabs.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
Esya Labs and HeioThera Receive $250,000 Investment from the โฆ
Jun 17, 2021 The 2021 Spring Cohort of the George Shultz Innovation Fund has invested $250,000 in both Esya Labs and HeioThera โ and this number will increase as they solidify โฆSee details»
Esya Labs Supports Drug Discovery Efforts at Novartis: โฆ
Apr 9, 2021 Esya Labs, which is developing several ground-breaking novel research assays, today has announced that Novartis is among the first companies to use its technology. Novartis, a global healthcare company, has โฆSee details»
Esya Labs Leads Paradigm Shift in Alzheimerโs Using Novel โฆ
Mar 8, 2021 Esya Labs is developing tools for the early, precise, and cost-effective detection of neurodegenerative diseases to support drug discovery and personalized medicine efforts. In โฆSee details»
Esya Labs Awarded $452,000 Grant from the Michael J. Fox โฆ
London, UK, November 4th, 2022 โ Esya Labs, a startup dedicated to developing early-stage biomarkers for neurodegenerative diseases, has been awarded a grant of $452,000 from The โฆSee details»
Esya Labs Provides Novel Research Assays to Accelerate Drug โฆ
Apr 6, 2021 CHICAGO--(BUSINESS WIRE)--Esya Labs, which is developing several ground-breaking novel research assays, today has announced that Novartis is among the first โฆSee details»
Esya for Alzheimer's - Esya Labs
Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. If you crave challenges and the chance to see your work impact the millions of lives โฆSee details»
ESYA Labs Partners with Alamar Biosciences to Advance Biomarker ...
11 hours ago DALLAS, December 04, 2024--(BUSINESS WIRE)--ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a โฆSee details»
Esya in the Press - Esya Labs
Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. If you crave challenges and the chance to see your work impact the millions of lives โฆSee details»
ESYA Labs Partners with Alamar Biosciences to Advance Biomarker ...
20 hours ago ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a transformative partnership with Alamar โฆSee details»
Esya Labs Awarded $452,000 Grant from the Michael J. Fox โฆ
Nov 23, 2022 Esya Labs, a startup dedicated to developing early-stage biomarkers for neurodegenerative diseases, has been awarded a grant of $452,000 from The Michael J. Fox โฆSee details»
Esya for Parkinson's - Esya Labs
Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. If you crave challenges and the chance to see your work impact the millions of lives โฆSee details»